Kimberly A. McDowell

651 total citations
22 papers, 480 citations indexed

About

Kimberly A. McDowell is a scholar working on Neurology, Oncology and Molecular Biology. According to data from OpenAlex, Kimberly A. McDowell has authored 22 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Neurology, 9 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Kimberly A. McDowell's work include CAR-T cell therapy research (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Neuroblastoma Research and Treatments (4 papers). Kimberly A. McDowell is often cited by papers focused on CAR-T cell therapy research (6 papers), Parkinson's Disease Mechanisms and Treatments (6 papers) and Neuroblastoma Research and Treatments (4 papers). Kimberly A. McDowell collaborates with scholars based in United States, Canada and Germany. Kimberly A. McDowell's co-authors include Marie‐Françoise Chesselet, Kenneth P. Roos, Paul M. Sondel, Kenneth B. DeSantes, Jacquelyn A. Hank, Paul Yarowsky, Sarah M. Clark, Christian M. Capitini, Jessica A. Mong and César Quiroz and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Neurology.

In The Last Decade

Kimberly A. McDowell

20 papers receiving 473 citations

Peers

Kimberly A. McDowell
Madeline J. Churchill United States
Kimberly A. McDowell
Citations per year, relative to Kimberly A. McDowell Kimberly A. McDowell (= 1×) peers Madeline J. Churchill

Countries citing papers authored by Kimberly A. McDowell

Since Specialization
Citations

This map shows the geographic impact of Kimberly A. McDowell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly A. McDowell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly A. McDowell more than expected).

Fields of papers citing papers by Kimberly A. McDowell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly A. McDowell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly A. McDowell. The network helps show where Kimberly A. McDowell may publish in the future.

Co-authorship network of co-authors of Kimberly A. McDowell

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly A. McDowell. A scholar is included among the top collaborators of Kimberly A. McDowell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly A. McDowell. Kimberly A. McDowell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meyers, Ross O., Kimberly A. McDowell, Margaret R. Jorgenson, et al.. (2025). A Phase I Study Evaluating Safety and Tolerability of Viral‐Specific T Cells Against BK‐Virus in Adult Kidney Transplant Recipients. Journal of Medical Virology. 97(4). e70357–e70357. 1 indexed citations
3.
DeSantes, Kenneth B., Kimberly A. McDowell, Paul M. Sondel, et al.. (2025). A Phase I, Open-Label, Dose Escalation Study of Enoblituzumab in Children and Young Adults with B7-H3–Expressing Relapsed or Refractory Solid Tumors. Cancer Research Communications. 5(9). 1574–1583. 1 indexed citations
4.
Blitzer, Grace C., Jayeeta Giri, Andrea Pennati, et al.. (2024). Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients – A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia. Radiotherapy and Oncology. 192. 110093–110093. 4 indexed citations
7.
Albertini, Mark R., Zachary S. Morris, Jacquelyn A. Hank, et al.. (2021). Phase I/II trial of intratumoral administration of hu14.18-IL2, with local radiation, nivolumab, and ipilimumab in subjects with advanced melanoma.. Journal of Clinical Oncology. 39(15_suppl). TPS9591–TPS9591. 2 indexed citations
8.
Forsberg, Matthew H., Kimberly A. McDowell, Myriam N. Bouchlaka, et al.. (2020). Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservation. Cytotherapy. 22(8). 450–457. 22 indexed citations
9.
McDowell, Kimberly A., et al.. (2018). Sleep Dysfunction and EEG Alterations in Mice Overexpressing Alpha-Synuclein. Journal of Parkinson s Disease. 4(3). 531–539. 44 indexed citations
10.
DeSantes, Kenneth B., John M. Maris, Kimberly A. McDowell, et al.. (2017). A phase 1, open-label, dose escalation study of enoblituzumab (MGA271) in pediatric patients with B7-H3-expressing relapsed or refractory solid tumors.. Journal of Clinical Oncology. 35(15_suppl). TPS2596–TPS2596. 15 indexed citations
11.
Richter, Franziska, Lauryn C. Gabby, Kimberly A. McDowell, et al.. (2016). Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice. Neurobiology of Aging. 51. 54–66. 29 indexed citations
12.
McDowell, Kimberly A., Jacquelyn A. Hank, Kenneth B. DeSantes, et al.. (2015). NK Cell-based Immunotherapies in Pediatric Oncology. Journal of Pediatric Hematology/Oncology. 37(2). 79–93. 17 indexed citations
13.
Navarro, Gemma, César Quiroz, David Moreno‐Delgado, et al.. (2015). Orexin–Corticotropin-Releasing Factor Receptor Heteromers in the Ventral Tegmental Area as Targets for Cocaine. Journal of Neuroscience. 35(17). 6639–6653. 61 indexed citations
14.
McDowell, Kimberly A. & Jennifer N. Clements. (2014). How can NSAIDs harm cardiovascular and renal function?. JAAPA. 27(4). 12–15. 4 indexed citations
15.
McDowell, Kimberly A. & Marie‐Françoise Chesselet. (2012). Animal models of the non-motor features of Parkinson's disease. Neurobiology of Disease. 46(3). 597–606. 120 indexed citations
16.
Alderson, Kory L., Amy K. Erbe, Kimberly A. McDowell, et al.. (2012). Increasing the Clinical Efficacy of NK and Antibody-Mediated Cancer Immunotherapy: Potential Predictors of Successful Clinical Outcome Based on Observations in High-Risk Neuroblastoma. Frontiers in Pharmacology. 3. 91–91. 29 indexed citations
17.
McDowell, Kimberly A., et al.. (2010). Sleep alterations in an environmental neurotoxin-induced model of parkinsonism. Experimental Neurology. 226(1). 84–89. 25 indexed citations
18.
Shen, Wei‐Bin, Kimberly A. McDowell, Sarah M. Clark, et al.. (2010). Environmental neurotoxin‐induced progressive model of parkinsonism in rats. Annals of Neurology. 68(1). 70–80. 38 indexed citations
19.
McDowell, Kimberly A., César Quiroz, Sergi Ferré, & Paul Yarowsky. (2010). The role of orexin and dopamine in sleep alterations from the progressive, neurotoxin‐induced model of parkinsonism. The FASEB Journal. 24(S1). 1 indexed citations
20.
Gibbs, Peter, Antonio Iannucci, Mike O’Driscoll, et al.. (2000). A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma. Melanoma Research. 10(2). 171–179. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026